微生物群和炎症标记:对它们的相互作用,临床影响和代谢障碍的审查
Emiliano Peña-Durán1, Jesús Jonathan García-Galindo2,3, Luis Daniel López-Murillo2,4
1Licenciatura en Médico Cirujano y Partero, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Mexico.
International journal of molecular sciences
|February 26, 2025
概括
人类微生物群影响免疫力和新陈代谢. 失生症或微生物失衡会增加炎症标志物,导致代谢和自身免疫性疾病,但向疗法显示出有前途.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 代谢科学 代谢科学
背景情况:
- 人类微生物群是一个复杂的微生物生态系统,对宿主免疫和新陈代谢至关重要.
- 微生物群组成和功能的变化 (失生症) 与慢性炎症和疾病有关.
- 关键的炎症生物标志物如CRP,IL-6,LPS,ZO-1和Ntn1都由微生物群调节.
研究的目的:
- 审查人类微生物群和炎症标志物之间的复杂关系.
- 强调这种相互作用对代谢和自身免疫性疾病的影响.
- 探索针对疾病管理的微生物群的治疗策略.
主要方法:
- 对研究微生物群,炎症和代谢/自身免疫性疾病的文献综述.
- 讨论特定的炎症生物标志物及其与肠道屏障完整性的联系.
- 分析治疗干预措施,如益生菌和益生菌.
主要成果:
- 失生症直接影响炎症生物标志物水平,加剧炎症并损害上皮屏障.
- 微生物群的破坏与增加的肠道透性相关,这是T2D,肥胖和NAFLD的前体.
- 治疗策略旨在恢复微生物平衡,减少炎症和改善代谢健康.
结论:
- 微生物群在调节炎症和代谢平衡中发挥着至关重要的作用.
- 针对微生物群的干预正在成为针对炎症和代谢疾病的精准医学的重要组成部分.
- 恢复微生物平衡为各种慢性疾病提供了一个有希望的治疗途径.
相关概念视频
Irritable Bowel Syndrome I: Introduction
218
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
218
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
294
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
294
Inflammatory Bowel Disease II: Crohn's Disease
157
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
157
Inflammatory Bowel Disease I: Ulcerative Colitis
112
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
112
Chronic Bowel Disorders: Introduction
378
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
378
Inflammatory Bowel Disease IV: Pharmacological Management
89
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
89


